-
1
-
-
52649097039
-
Granulosa cell tumor of the ovary: Tumor review
-
Koukourakis GV, Kouloulias VE, Koukourakis MJ, Zacharias GA, Papadimitriou C, Mystakidou K, Pistevou-Gompaki K, Kouvaris J, and Gouliamos A (2008). Granulosa cell tumor of the ovary: tumor review. Integr Cancer Ther 7, 204-215.
-
(2008)
Integr Cancer Ther
, vol.7
, pp. 204-215
-
-
Koukourakis, G.V.1
Kouloulias, V.E.2
Koukourakis, M.J.3
Zacharias, G.A.4
Papadimitriou, C.5
Mystakidou, K.6
Pistevou-Gompaki, K.7
Kouvaris, J.8
Gouliamos, A.9
-
2
-
-
45949087056
-
Glucose metabolism and angiogenesis in granulosa cell tumors of the ovary: Activation of Akt, expression of M2PK, TKTL1 and VEGF
-
Schmidt M, Kammerer U, Segerer S, Cramer A, Kohrenhagen N, Dietl J, and Voelker HU (2008). Glucose metabolism and angiogenesis in granulosa cell tumors of the ovary: activation of Akt, expression of M2PK, TKTL1 and VEGF. Eur J Obstet Gynecol Reprod Biol 139, 72-78.
-
(2008)
Eur J Obstet Gynecol Reprod Biol
, vol.139
, pp. 72-78
-
-
Schmidt, M.1
Kammerer, U.2
Segerer, S.3
Cramer, A.4
Kohrenhagen, N.5
Dietl, J.6
Voelker, H.U.7
-
3
-
-
0037445186
-
Granulosa cell tumor of the ovary
-
Schumer ST and Cannistra SA (2003). Granulosa cell tumor of the ovary. J Clin Oncol 21, 1180-1189.
-
(2003)
J Clin Oncol
, vol.21
, pp. 1180-1189
-
-
Schumer, S.T.1
Cannistra, S.A.2
-
4
-
-
67651160319
-
Anti-angiogenesis therapy with bevacizumab for patients with ovarian granulosa cell tumors
-
Tao X, Sood AK, Deavers MT, Schmeler KM, Nick AM, Coleman RL, Milojevic L, Gershenson DM, and Brown J (2009). Anti-angiogenesis therapy with bevacizumab for patients with ovarian granulosa cell tumors. Gynecol Oncol 114, 431-436.
-
(2009)
Gynecol Oncol
, vol.114
, pp. 431-436
-
-
Tao, X.1
Sood, A.K.2
Deavers, M.T.3
Schmeler, K.M.4
Nick, A.M.5
Coleman, R.L.6
Milojevic, L.7
Gershenson, D.M.8
Brown, J.9
-
5
-
-
77953375611
-
Prognostic factors in adult granulosa cell tumors of the ovary: A retrospective analysis of 80 cases
-
Ayhan A, Salman MC, Velipasaoglu M, Sakinci M, and Yuce K (2009). Prognostic factors in adult granulosa cell tumors of the ovary: a retrospective analysis of 80 cases. J Gynecol Oncol 20, 158-163.
-
(2009)
J Gynecol Oncol
, vol.20
, pp. 158-163
-
-
Ayhan, A.1
Salman, M.C.2
Velipasaoglu, M.3
Sakinci, M.4
Yuce, K.5
-
6
-
-
0030003603
-
Mitotic count, nuclear atypia, and immunohistochemical determination of Ki-67, c-myc, p21-ras, c-erbB2, and p53 expression in granulosa cell tumors of the ovary: Mitotic count and Ki-67 are indicators of poor prognosis
-
King LA, Okagaki T, Gallup DG, Twiggs LB, Messing MJ, and Carson LF (1996). Mitotic count, nuclear atypia, and immunohistochemical determination of Ki-67, c-myc, p21-ras, c-erbB2, and p53 expression in granulosa cell tumors of the ovary: mitotic count and Ki-67 are indicators of poor prognosis. Gynecol Oncol 61, 227-232.
-
(1996)
Gynecol Oncol
, vol.61
, pp. 227-232
-
-
King, L.A.1
Okagaki, T.2
Gallup, D.G.3
Twiggs, L.B.4
Messing, M.J.5
Carson, L.F.6
-
7
-
-
0030743165
-
Control of differentiation, transformation, and apoptosis in granulosa cells by oncogenes, oncoviruses, and tumor suppressor genes
-
Amsterdam A and Selvaraj N (1997). Control of differentiation, transformation, and apoptosis in granulosa cells by oncogenes, oncoviruses, and tumor suppressor genes. Endocr Rev 18, 435-461.
-
(1997)
Endocr Rev
, vol.18
, pp. 435-461
-
-
Amsterdam, A.1
Selvaraj, N.2
-
8
-
-
0029932105
-
Recurrent granulosa cell tumor of the ovary 37 years after initial diagnosis: A case report and review of the literature
-
Hines JF, Khalifa MA, Moore JL, Fine KP, Lage JM, and Barnes WA (1996). Recurrent granulosa cell tumor of the ovary 37 years after initial diagnosis: a case report and review of the literature. Gynecol Oncol 60, 484-488.
-
(1996)
Gynecol Oncol
, vol.60
, pp. 484-488
-
-
Hines, J.F.1
Khalifa, M.A.2
Moore, J.L.3
Fine, K.P.4
Lage, J.M.5
Barnes, W.A.6
-
10
-
-
84857837160
-
Molecular pathogenesis of granulosa cell tumors of the ovary
-
Jamieson S and Fuller PJ (2012). Molecular pathogenesis of granulosa cell tumors of the ovary. Endocr Rev 33, 109-144.
-
(2012)
Endocr Rev
, vol.33
, pp. 109-144
-
-
Jamieson, S.1
Fuller, P.J.2
-
11
-
-
84856009067
-
A long-term follow-up study of 176 cases with adult-type ovarian granulosa cell tumors
-
Sun HD, Lin H, Jao MS, Wang KL, Liou WS, Hung YC, Chiang YC, Lu CH, Lai HC, and Yu MH (2012). A long-term follow-up study of 176 cases with adult-type ovarian granulosa cell tumors. Gynecol Oncol 124, 244-249.
-
(2012)
Gynecol Oncol
, vol.124
, pp. 244-249
-
-
Sun, H.D.1
Lin, H.2
Jao, M.S.3
Wang, K.L.4
Liou, W.S.5
Hung, Y.C.6
Chiang, Y.C.7
Lu, C.H.8
Lai, H.C.9
Yu, M.H.10
-
12
-
-
0028052989
-
Granulosa cell tumors of the ovary: Prognostic factors and outcome
-
Malmstrom H, Hogberg T, Risberg B, and Simonsen E (1994). Granulosa cell tumors of the ovary: prognostic factors and outcome. Gynecol Oncol 52, 50-55.
-
(1994)
Gynecol Oncol
, vol.52
, pp. 50-55
-
-
Malmstrom, H.1
Hogberg, T.2
Risberg, B.3
Simonsen, E.4
-
13
-
-
84862819234
-
Surgical staging and adjuvant chemotherapy in the management of patients with adult granulosa cell tumors of the ovary
-
Park JY, Jin KL, Kim DY, Kim JH, Kim YM, Kim KR, Kim YT, and Nam JH (2012). Surgical staging and adjuvant chemotherapy in the management of patients with adult granulosa cell tumors of the ovary. Gynecol Oncol 125, 80-86.
-
(2012)
Gynecol Oncol
, vol.125
, pp. 80-86
-
-
Park, J.Y.1
Jin, K.L.2
Kim, D.Y.3
Kim, J.H.4
Kim, Y.M.5
Kim, K.R.6
Kim, Y.T.7
Nam, J.H.8
-
14
-
-
0029898820
-
Leuprolide acetate for treating refractory or persistent ovarian granulosa cell tumor
-
Fishman A, Kudelka AP, Tresukosol D, Edwards CL, Freedman RS, Kaplan AL, Girtanner RE, and Kavanagh JJ (1996). Leuprolide acetate for treating refractory or persistent ovarian granulosa cell tumor. J Reprod Med 41, 393-396.
-
(1996)
J Reprod Med
, vol.41
, pp. 393-396
-
-
Fishman, A.1
Kudelka, A.P.2
Tresukosol, D.3
Edwards, C.L.4
Freedman, R.S.5
Kaplan, A.L.6
Girtanner, R.E.7
Kavanagh, J.J.8
-
15
-
-
84856305309
-
Aromatase inhibitors in the treatment of recurrent ovarian granulosa cell tumors: Brief report and review of the literature
-
Alhilli MM, Long HJ, Podratz KC, and Bakkum-Gamez JN (2012). Aromatase inhibitors in the treatment of recurrent ovarian granulosa cell tumors: brief report and review of the literature. J Obstet Gynaecol Res 38, 340-344.
-
(2012)
J Obstet Gynaecol Res
, vol.38
, pp. 340-344
-
-
Alhilli, M.M.1
Long, H.J.2
Podratz, K.C.3
Bakkum-Gamez, J.N.4
-
16
-
-
84864011864
-
Third-line chemotherapy with tyrosine kinase inhibitor (imatinib mesylate) in recurrent ovarian granulosa cell tumor: Case report
-
Raspagliesi F, Martinelli F, Grijuela B, and Guadalupi V (2011). Third-line chemotherapy with tyrosine kinase inhibitor (imatinib mesylate) in recurrent ovarian granulosa cell tumor: case report. J Obstet Gynaecol Res 37, 1864-1867.
-
(2011)
J Obstet Gynaecol Res
, vol.37
, pp. 1864-1867
-
-
Raspagliesi, F.1
Martinelli, F.2
Grijuela, B.3
Guadalupi, V.4
-
17
-
-
78751553690
-
Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are highly expressed in ovarian granulosa cell tumors
-
Farkkila A, Anttonen M, Pociuviene J, Leminen A, Butzow R, Heikinheimo M, and Unkila-Kallio L (2011). Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are highly expressed in ovarian granulosa cell tumors. Eur J Endocrinol 164, 115-122.
-
(2011)
Eur J Endocrinol
, vol.164
, pp. 115-122
-
-
Farkkila, A.1
Anttonen, M.2
Pociuviene, J.3
Leminen, A.4
Butzow, R.5
Heikinheimo, M.6
Unkila-Kallio, L.7
-
18
-
-
83155168437
-
Serum vascular endothelial growth factor A (VEGF) is elevated in patients with ovarian granulosa cell tumor (GCT), and VEGF inhibition by bevacizumab induces apoptosis in GCT in vitro
-
Farkkila A, Pihlajoki M, Tauriala H, Butzow R, Leminen A, Unkila-Kallio L, Heikinheimo M, and Anttonen M (2011). Serum vascular endothelial growth factor A (VEGF) is elevated in patients with ovarian granulosa cell tumor (GCT), and VEGF inhibition by bevacizumab induces apoptosis in GCT in vitro. J Clin Endocrinol Metab 96, E1973-E1981.
-
(2011)
J Clin Endocrinol Metab
, vol.96
-
-
Farkkila, A.1
Pihlajoki, M.2
Tauriala, H.3
Butzow, R.4
Leminen, A.5
Unkila-Kallio, L.6
Heikinheimo, M.7
Anttonen, M.8
-
19
-
-
34447108810
-
Vascular endothelial growth factor: Biology and therapeutic applications
-
Ho QT and Kuo CJ (2007). Vascular endothelial growth factor: biology and therapeutic applications. Int J Biochem Cell Biol 39, 1349-1357.
-
(2007)
Int J Biochem Cell Biol
, vol.39
, pp. 1349-1357
-
-
Ho, Q.T.1
Kuo, C.J.2
-
20
-
-
70350655979
-
VEGF as an inhibitor of tumor vessel maturation: Implications for cancer therapy
-
Greenberg JI and Cheresh DA (2009). VEGF as an inhibitor of tumor vessel maturation: implications for cancer therapy. Expert Opin Biol Ther 9, 1347-1356.
-
(2009)
Expert Opin Biol Ther
, vol.9
, pp. 1347-1356
-
-
Greenberg, J.I.1
Cheresh, D.A.2
-
21
-
-
0037699954
-
The biology of VEGF and its receptors
-
Ferrara N, Gerber HP, and LeCouter J (2003). The biology of VEGF and its receptors. Nat Med 9, 669-676.
-
(2003)
Nat Med
, vol.9
, pp. 669-676
-
-
Ferrara, N.1
Gerber, H.P.2
LeCouter, J.3
-
22
-
-
77954385088
-
Direct survival role of vascular endothelial growth factor (VEGF) on rat ovarian follicular cells
-
Irusta G, Abramovich D, Parborell F, and Tesone M (2010). Direct survival role of vascular endothelial growth factor (VEGF) on rat ovarian follicular cells. Mol Cell Endocrinol 325, 93-100.
-
(2010)
Mol Cell Endocrinol
, vol.325
, pp. 93-100
-
-
Irusta, G.1
Abramovich, D.2
Parborell, F.3
Tesone, M.4
-
23
-
-
34848865001
-
Vascular endothelial growth factor (VEGF) suppresses ovarian granulosa cell apoptosis in vitro
-
Kosaka N, Sudo N, Miyamoto A, and Shimizu T (2007). Vascular endothelial growth factor (VEGF) suppresses ovarian granulosa cell apoptosis in vitro. Biochem Biophys Res Commun 363, 733-737.
-
(2007)
Biochem Biophys Res Commun
, vol.363
, pp. 733-737
-
-
Kosaka, N.1
Sudo, N.2
Miyamoto, A.3
Shimizu, T.4
-
24
-
-
2542490291
-
Vascular endothelial growth factor and its receptor, Flk-1/KDR, are cytoprotective in the extravascular compartment of the ovarian follicle
-
Greenaway J, Connor K, Pedersen HG, Coomber BL, LaMarre J, and Petrik J (2004). Vascular endothelial growth factor and its receptor, Flk-1/KDR, are cytoprotective in the extravascular compartment of the ovarian follicle. Endocrinology 145, 2896-2905.
-
(2004)
Endocrinology
, vol.145
, pp. 2896-2905
-
-
Greenaway, J.1
Connor, K.2
Pedersen, H.G.3
Coomber, B.L.4
LaMarre, J.5
Petrik, J.6
-
25
-
-
2542561964
-
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
-
Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, et al. (2004). Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350, 2335-2342.
-
(2004)
N Engl J Med
, vol.350
, pp. 2335-2342
-
-
Hurwitz, H.1
Fehrenbacher, L.2
Novotny, W.3
Cartwright, T.4
Hainsworth, J.5
Heim, W.6
Berlin, J.7
Baron, A.8
Griffing, S.9
Holmgren, E.10
-
26
-
-
33845490014
-
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer
-
Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A, Lilenbaum R, and Johnson DH (2006). Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 355, 2542-2550.
-
(2006)
N Engl J Med
, vol.355
, pp. 2542-2550
-
-
Sandler, A.1
Gray, R.2
Perry, M.C.3
Brahmer, J.4
Schiller, J.H.5
Dowlati, A.6
Lilenbaum, R.7
Johnson, D.H.8
-
27
-
-
34547519439
-
+/min mice
-
+/min mice. Proc Natl Acad Sci USA 104, 10625-10630.
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, pp. 10625-10630
-
-
Korsisaari, N.1
Kasman, I.M.2
Forrest, W.F.3
Pal, N.4
Bai, W.5
Fuh, G.6
Peale, F.V.7
Smits, R.8
Ferrara, N.9
-
28
-
-
84855425106
-
Incorporation of bevacizumab in the primary treatment of ovarian cancer
-
Burger RA, Brady MF, Bookman MA, Fleming GF, Monk BJ, Huang H, Mannel RS, Homesley HD, Fowler J, Greer BE, et al. (2011). Incorporation of bevacizumab in the primary treatment of ovarian cancer. N Engl J Med 365, 2473-2483.
-
(2011)
N Engl J Med
, vol.365
, pp. 2473-2483
-
-
Burger, R.A.1
Brady, M.F.2
Bookman, M.A.3
Fleming, G.F.4
Monk, B.J.5
Huang, H.6
Mannel, R.S.7
Homesley, H.D.8
Fowler, J.9
Greer, B.E.10
-
29
-
-
33745923690
-
Salvage bevacizumab (rhuMAB VEGF)-based therapy after multiple prior cytotoxic regimens in advanced refractory epithelial ovarian cancer
-
Monk BJ, Han E, Josephs-Cowan CA, Pugmire G, and Burger RA (2006). Salvage bevacizumab (rhuMAB VEGF)-based therapy after multiple prior cytotoxic regimens in advanced refractory epithelial ovarian cancer. Gynecol Oncol 102, 140-144.
-
(2006)
Gynecol Oncol
, vol.102
, pp. 140-144
-
-
Monk, B.J.1
Han, E.2
Josephs-Cowan, C.A.3
Pugmire, G.4
Burger, R.A.5
-
30
-
-
56449105264
-
Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian cancer
-
Richardson DL, Backes FJ, Seamon LG, Zanagnolo V, O'Malley DM, Cohn DE, Fowler JM, and Copeland LJ (2008). Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian cancer. Gynecol Oncol 111, 461-466.
-
(2008)
Gynecol Oncol
, vol.111
, pp. 461-466
-
-
Richardson, D.L.1
Backes, F.J.2
Seamon, L.G.3
Zanagnolo, V.4
O'Malley, D.M.5
Cohn, D.E.6
Fowler, J.M.7
Copeland, L.J.8
-
31
-
-
56449083159
-
The use of bevacizumab in refractory ovarian granulosa-cell carcinoma with symptomatic relief of ascites: A case report
-
Kesterson JP, Mhawech-Fauceglia P, and Lele S (2008). The use of bevacizumab in refractory ovarian granulosa-cell carcinoma with symptomatic relief of ascites: a case report. Gynecol Oncol 111, 527-529.
-
(2008)
Gynecol Oncol
, vol.111
, pp. 527-529
-
-
Kesterson, J.P.1
Mhawech-Fauceglia, P.2
Lele, S.3
-
32
-
-
78650234556
-
Neoadjuvant bevacizumab in a granulosa cell tumor of the ovary: A case report
-
Barrena Medel NI, Herzog TJ, Wright JD, and Lewin SN (2010). Neoadjuvant bevacizumab in a granulosa cell tumor of the ovary: a case report. Anticancer Res 30, 4767-4768.
-
(2010)
Anticancer Res
, vol.30
, pp. 4767-4768
-
-
Barrena Medel, N.I.1
Herzog, T.J.2
Wright, J.D.3
Lewin, S.N.4
-
34
-
-
84859415438
-
Minireview: Animal models and mechanisms of ovarian cancer development
-
Mullany LK and Richards JS (2012). Minireview: animal models and mechanisms of ovarian cancer development. Endocrinology 153, 1585-1592.
-
(2012)
Endocrinology
, vol.153
, pp. 1585-1592
-
-
Mullany, L.K.1
Richards, J.S.2
-
35
-
-
56049110836
-
Synergistic effects of Pten loss and WNT/CTNNB1 signaling pathway activation in ovarian granulosa cell tumor development and progression
-
Lague MN, Paquet M, Fan HY, Kaartinen MJ, Chu S, Jamin SP, Behringer RR, Fuller PJ, Mitchell A, Dore M, et al. (2008). Synergistic effects of Pten loss and WNT/CTNNB1 signaling pathway activation in ovarian granulosa cell tumor development and progression. Carcinogenesis 29, 2062-2072.
-
(2008)
Carcinogenesis
, vol.29
, pp. 2062-2072
-
-
Lague, M.N.1
Paquet, M.2
Fan, H.Y.3
Kaartinen, M.J.4
Chu, S.5
Jamin, S.P.6
Behringer, R.R.7
Fuller, P.J.8
Mitchell, A.9
Dore, M.10
-
36
-
-
76049126428
-
A mouse surgical model for metastatic ovarian granulosa cell tumor
-
Nadeau ME, Kaartinen MJ, Lague MN, Paquet M, Huneault LM, and Boerboom D (2009). A mouse surgical model for metastatic ovarian granulosa cell tumor. Comp Med 59, 553-556.
-
(2009)
Comp Med
, vol.59
, pp. 553-556
-
-
Nadeau, M.E.1
Kaartinen, M.J.2
Lague, M.N.3
Paquet, M.4
Huneault, L.M.5
Boerboom, D.6
-
37
-
-
43449101471
-
Combination of bleomycin, etoposide, and cisplatin for the treatment of advanced ovarian granulosa cell tumors
-
Pautier P, Gutierrez-Bonnaire M, Rey A, Sillet-Bach I, Chevreau C, Kerbrat P, Morice P, Duvillard P, and Lhomme C (2008). Combination of bleomycin, etoposide, and cisplatin for the treatment of advanced ovarian granulosa cell tumors. Int J Gynecol Cancer 18, 446-452.
-
(2008)
Int J Gynecol Cancer
, vol.18
, pp. 446-452
-
-
Pautier, P.1
Gutierrez-Bonnaire, M.2
Rey, A.3
Sillet-Bach, I.4
Chevreau, C.5
Kerbrat, P.6
Morice, P.7
Duvillard, P.8
Lhomme, C.9
-
38
-
-
18144364695
-
The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors
-
Brown J, Shvartsman HS, Deavers MT, Ramondetta LM, Burke TW, Munsell MF, and Gershenson DM (2005). The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors. Gynecol Oncol 97, 489-496.
-
(2005)
Gynecol Oncol
, vol.97
, pp. 489-496
-
-
Brown, J.1
Shvartsman, H.S.2
Deavers, M.T.3
Ramondetta, L.M.4
Burke, T.W.5
Munsell, M.F.6
Gershenson, D.M.7
-
39
-
-
0034098405
-
Signaling angiogenesis via p42/p44 MAP kinase cascade
-
Pages G, Milanini J, Richard DE, Berra E, Gothie E, Vinals F, and Pouyssegur J (2000). Signaling angiogenesis via p42/p44 MAP kinase cascade. Ann N Y Acad Sci 902, 187-200.
-
(2000)
Ann N Y Acad Sci
, vol.902
, pp. 187-200
-
-
Pages, G.1
Milanini, J.2
Richard, D.E.3
Berra, E.4
Gothie, E.5
Vinals, F.6
Pouyssegur, J.7
-
40
-
-
0034531952
-
MAP kinases and hypoxia in the control of VEGF expression
-
Berra E, Pages G, and Pouyssegur J (2000). MAP kinases and hypoxia in the control of VEGF expression. Cancer Metastasis Rev 19, 139-145.
-
(2000)
Cancer Metastasis Rev
, vol.19
, pp. 139-145
-
-
Berra, E.1
Pages, G.2
Pouyssegur, J.3
-
41
-
-
84860468850
-
165b expression regulates follicular development, corpus luteum function and fertility
-
165b expression regulates follicular development, corpus luteum function and fertility. Reproduction 143, 501-511.
-
(2012)
Reproduction
, vol.143
, pp. 501-511
-
-
Qiu, Y.1
Seager, M.2
Osman, A.3
Castle-Miller, J.4
Bevan, H.5
Tortonese, D.J.6
Murphy, D.7
Harper, S.J.8
Fraser, H.M.9
Donaldson, L.F.10
-
42
-
-
33646758105
-
Role of vascular endothelial growth factor in ovarian physiology-an overview
-
Kaczmarek MM, Schams D, and Ziecik AJ (2005). Role of vascular endothelial growth factor in ovarian physiology-an overview. Reprod Biol 5, 111-136.
-
(2005)
Reprod Biol
, vol.5
, pp. 111-136
-
-
Kaczmarek, M.M.1
Schams, D.2
Ziecik, A.J.3
-
43
-
-
67649814136
-
PI3K/PTEN signaling in angiogenesis and tumorigenesis
-
Jiang BH and Liu LZ (2009). PI3K/PTEN signaling in angiogenesis and tumorigenesis. Adv Cancer Res 102, 19-65.
-
(2009)
Adv Cancer Res
, vol.102
, pp. 19-65
-
-
Jiang, B.H.1
Liu, L.Z.2
-
44
-
-
74049134054
-
PTEN regulates angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells
-
Ma J, Sawai H, Ochi N, Matsuo Y, Xu D, Yasuda A, Takahashi H, Wakasugi T, and Takeyama H (2009). PTEN regulates angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells. Mol Cell Biochem 331, 161-171.
-
(2009)
Mol Cell Biochem
, vol.331
, pp. 161-171
-
-
Ma, J.1
Sawai, H.2
Ochi, N.3
Matsuo, Y.4
Xu, D.5
Yasuda, A.6
Takahashi, H.7
Wakasugi, T.8
Takeyama, H.9
-
45
-
-
0031898292
-
Neutralizing anti-vascular endothelial growth factor antibody completely inhibits angiogenesis and growth of human prostate carcinoma micro tumors in vivo
-
Borgström P, Bourdon MA, Hillan KJ, Sriramarao P, and Ferrara N (1998). Neutralizing anti-vascular endothelial growth factor antibody completely inhibits angiogenesis and growth of human prostate carcinoma micro tumors in vivo. Prostate 35, 1-10.
-
(1998)
Prostate
, vol.35
, pp. 1-10
-
-
Borgström, P.1
Bourdon, M.A.2
Hillan, K.J.3
Sriramarao, P.4
Ferrara, N.5
-
46
-
-
3042548695
-
Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts
-
Inai T, Mancuso M, Hashizume H, Baffert F, Haskell A, Baluk P, Hu-Lowe DD, Shalinsky DR, Thurston G, Yancopoulos GD, et al. (2004). Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. Am J Pathol 165, 35-52.
-
(2004)
Am J Pathol
, vol.165
, pp. 35-52
-
-
Inai, T.1
Mancuso, M.2
Hashizume, H.3
Baffert, F.4
Haskell, A.5
Baluk, P.6
Hu-Lowe, D.D.7
Shalinsky, D.R.8
Thurston, G.9
Yancopoulos, G.D.10
-
47
-
-
79960096827
-
Normalization of the vasculature for treatment of cancer and other diseases
-
Goel S, Duda DG, Xu L, Munn LL, Boucher Y, Fukumura D, and Jain RK (2011). Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev 91, 1071-1121.
-
(2011)
Physiol Rev
, vol.91
, pp. 1071-1121
-
-
Goel, S.1
Duda, D.G.2
Xu, L.3
Munn, L.L.4
Boucher, Y.5
Fukumura, D.6
Jain, R.K.7
-
48
-
-
11844254414
-
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
-
Jain RK (2005). Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307, 58-62.
-
(2005)
Science
, vol.307
, pp. 58-62
-
-
Jain, R.K.1
|